Complement Receive IND Clearance to Advance CTx001 into Opti-GAIN
08 Oct 2025 //
PR NEWSWIRE
Dianthus Therapeutics Completes Enrollment Ph 2 Trial of DNTH103
05 May 2025 //
GLOBENEWSWIRE
Complement Therapeutics Appoints Dr Parisa Zamiri MD, as Chief Medical Officer
03 Aug 2023 //
PR NEWSWIRE
Complement Therapeutics Secures €72 Million in Series A Financing
17 Apr 2023 //
PR NEWSWIRE

Market Place
Sourcing Support